RecruitingNCT07571564

Adherence to Enteral Nutrition


Sponsor

Institut Curie

Enrollment

80 participants

Start Date

Mar 5, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Malnutrition is a major challenge in cancer nutrition, affecting approximately 40% of cancer patients and having negative consequences on treatment efficacy, quality of life, and prognosis. It must be detected and managed early, based on clinical and laboratory criteria defined by the HAS recommendations. To address this, several nutritional strategies are available, ranging from fortified oral feeding to artificial nutrition. Enteral nutrition, which is more physiological and carries fewer risks than parenteral nutrition, is recommended as the first-line treatment. Tools such as personalized care plans and guidelines help tailor patient care. However, enteral nutrition remains underutilized in clinical practice, despite the recommendations. The ADHENUTE study, conducted at the Institut Curie, showed low compliance with recommendations (31%) and a tendency to favor oral nutritional supplements, even in severely malnourished patients. The lack of traceability of decisions makes it difficult to identify barriers, although patient refusal is sometimes mentioned. To improve this situation, corrective measures have been implemented: * for patients, through educational workshops to help them better understand and accept enteral nutrition; * for healthcare providers, through training sessions to address reservations and enhance knowledge. A third phase of the study aims to evaluate the impact of these actions, with the goal of increasing adherence to recommendations and the use of enteral nutrition.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria4

  • Patients hospitalized (including those in the day hospital) in a medical oncology unit;
  • Adults;
  • Men or women;
  • Patients for whom enteral nutrition is indicated according to SFNCM recommendations;

Exclusion Criteria7

  • Minors (under 18 years of age)
  • Patients receiving end-of-life palliative care
  • Individuals deprived of their liberty or under legal guardianship (including conservatorship);
  • Adults under judicial protection;
  • Inability to participate in the study for geographical, social, or psychological reasons.
  • Persons referred to in Articles L. 1121-5 through L. 1121-8 and L. 1122-1-2 of the Public Health Code (e.g., minors, adults under guardianship, etc.).
  • Patients who do not speak or understand French.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Institut Curie

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07571564


Related Trials